Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-10-03
2000-05-09
Carr, Deborah D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514557, 554156, 554202, 554206, 554223, 554224, A61K 3120
Patent
active
060605111
ABSTRACT:
The use of crocetin has been demonstrated to be effective in elevating oxygen diffusivity, and increasing oxygen consumption by the body tissues of a mammal. Crocetin is difficult to solubilize. Sodium crocetinate, formed by reacting crocetin with sodium hydroxide, appears in several isomeric forms. The trans isomer is effective in improving oxygen diffusivity, while the related cis isomer appears not to be. Isolated TSC can be used in place of crocetin, treat a variety of conditions, including hypertension, cardiovascular disease, hemorrhagic shock, papillomas and related conditions.
REFERENCES:
patent: 4046880 (1977-09-01), Gainer
patent: 4176179 (1979-11-01), Gainer
Streitwieser et al., Introduction to Organic Chemistry, 2nd ed., pp. 504-505, 1981.
LandOfFree
Trans-sodium crocetinate, methods of making and methods of use t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trans-sodium crocetinate, methods of making and methods of use t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trans-sodium crocetinate, methods of making and methods of use t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1065661